ArticleMolecular oncology2022

Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment.

John C Dawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.